Journals / MN Oftalmoloji / 2008 / Cilt: 15 - Sayı: 4

Intravitreal bevacizumab treatment in choroidal neovascularization secondary to central serous chorioretinopathy

Santral seröz korioretinopatiye bağlı koroid neovaskülarizasyonunda intravitreal bevacizumab tedavisi

Pages
267–270
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

During follow-up no CNV recurrence was seen.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Two eyes of two patients with choroidal neovascularization (CNV) secondary to central serous chorioretinopathy (CSR) received 1.25 mg/0.05 ml intravitreal bevacizumab injection.
📊
Key Findings & Data:After treatment visual acuity increased from 3/10 and 2/10 to 9/10 and 8/10.
💡
Conclusion & Impact:During follow-up no CNV recurrence was seen.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Koroidal neovaskülarizasyon · Kadın · Floresan anjiyografi

Abstract

Two eyes of two patients with choroidal neovascularization (CNV) secondary to central serous chorioretinopathy (CSR) received 1.25 mg/0.05 ml intravitreal bevacizumab injection. Examinations included visual acuity measurement (ETDRS), fundus biomicroscopy, fundus fluorescein angiography (FFA) and optical coherence tomography (OCT). Patients were observed for six months. After treatment visual acuity increased from 3/10 and 2/10 to 9/10 and 8/10. There was no fluorescein leakage and no subretinal fluid at the last examination. During follow-up no CNV recurrence was seen.

Özet

Santral seröz korioretinopatiye (SSR) bağlı olarak gelişen koroid neovaskülarizasyonu (KNV) bulunan iki olgunun, iki gözüne 1,25 mg/0,05 ml intravitreal bevacizumab injeksiyonu uygulandı. Olguların ETDRS eşeli ile görme keskinliği ölçüldü, fundus biyomikroskopik değerlendirmesi yapıldı, fundus flöresein anjiografi (FFA) ve optik koherens tomografi (OKT) çekimleri yapıldı. Hastalar 6 ay takip edildiler. Tedavi sonrası görme keskinliği 3/10 ve 2/10 seviyelerinden sırasıyla 9/10 ve 8/10 seviyesine yükseldi. Son muayenenede flöresein sızıntısı ve retina altı sıvı birikimi yoktu. Takip süresi içinde KNV’de nüks gözlenmedi.

🔖

Cite This Article

ŞENTÜRK, F., ÖZDEMİR, H., KARAÇORLU, S. A., KARAÇORLU, M. (2008). Intravitreal bevacizumab treatment in choroidal neovascularization secondary to central serous chorioretinopathy. MN Oftalmoloji, Cilt: 15 - Sayı: 4, 267–270. https://ajindex.com/articles/296779

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Yannuzzi LA, Shakin JL, Fisher YL, Altomonte MA. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology 1984;91:1554-72. 2.Cooper BA, Thomas MA. Submacular surgery to remove choroidal neovascularization associated with central serous chorioretinopathy. Am J Ophthalmol 2000;130:187-91. 3.Macular Photocoagulation Study Group. Argon laser photo-coagulation for idiopathic neovascularization: Results of a randomized clinical trial. Arch Ophthalmol 1983; 101:1358-61. 4.Chan WM, Lam DS, Lai TY, Yuen KS, Liu DT, et al. Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin. Am J Ophthalmol 2003; 136:836-45. 5.Rosenfelt PJ. Intfavitreal avastin: the low cost alternative to lucentis? Am J Ophthalmol 2006;142:141-3. 6.Chan WM, Lai TY, Liu DT, Lam DS. İntravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 2007;143:977-83.